Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study

Abstract The digit ratio has been used as a retrospective noninvasive biomarker to investigate the putative effects of prenatal exposure to androgens. In recent years, many scholars have paid attention to the association between 2D:4D (the second and fourth digits) and prostatic cancer. This study e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guanjian Li, Ke Sun, Jie Guo, Shixing Li, Bo Li, Jing Cao, Pengfei Lu, Jiajia Yang, Ying Zhang, Xin Yang, Le Gao, Yi He, Tao Cui, Bin Ma
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5c38dd54e6f544a78063c2493a254cae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5c38dd54e6f544a78063c2493a254cae
record_format dspace
spelling oai:doaj.org-article:5c38dd54e6f544a78063c2493a254cae2021-12-02T11:51:13ZPrognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study10.1038/s41598-017-05638-w2045-2322https://doaj.org/article/5c38dd54e6f544a78063c2493a254cae2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05638-whttps://doaj.org/toc/2045-2322Abstract The digit ratio has been used as a retrospective noninvasive biomarker to investigate the putative effects of prenatal exposure to androgens. In recent years, many scholars have paid attention to the association between 2D:4D (the second and fourth digits) and prostatic cancer. This study explored the prognostic significance of digit ratio in prostate cancer patients. We reviewed the progressive status and survival of 382 prostate cancer patients who had received hormone therapy at our institutions. Survival of clinicopathological variables analyzed as categorical variables were determined by the log-rank test. According to Cox’s proportional hazards analysis, R2D:4D, L2D:4D, PSA at 6 month,bone metastasis were significant independent factors for prostate cancer. The risk of any progression of prostate cancer similarly depressed with increasing 2D:4D, for any progression (R2D:4D HR = 0.71, p = 0.003; L2D:4D HR = 0.67, p = 0.001), for cancer-specific death (R2D:4D HR = 0.67, p = 0.025; L2D:4D HR = 0.74, p = 0.036). Digit ratio may not only have predictive value in risk but also prognosis of prostatic cancer. This finding suggests that low 2D:4D can be used as prognostic factors to identify patients with a poor prognosis. These patients may benefit from more aggressive management.Guanjian LiKe SunJie GuoShixing LiBo LiJing CaoPengfei LuJiajia YangYing ZhangXin YangLe GaoYi HeTao CuiBin MaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Guanjian Li
Ke Sun
Jie Guo
Shixing Li
Bo Li
Jing Cao
Pengfei Lu
Jiajia Yang
Ying Zhang
Xin Yang
Le Gao
Yi He
Tao Cui
Bin Ma
Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
description Abstract The digit ratio has been used as a retrospective noninvasive biomarker to investigate the putative effects of prenatal exposure to androgens. In recent years, many scholars have paid attention to the association between 2D:4D (the second and fourth digits) and prostatic cancer. This study explored the prognostic significance of digit ratio in prostate cancer patients. We reviewed the progressive status and survival of 382 prostate cancer patients who had received hormone therapy at our institutions. Survival of clinicopathological variables analyzed as categorical variables were determined by the log-rank test. According to Cox’s proportional hazards analysis, R2D:4D, L2D:4D, PSA at 6 month,bone metastasis were significant independent factors for prostate cancer. The risk of any progression of prostate cancer similarly depressed with increasing 2D:4D, for any progression (R2D:4D HR = 0.71, p = 0.003; L2D:4D HR = 0.67, p = 0.001), for cancer-specific death (R2D:4D HR = 0.67, p = 0.025; L2D:4D HR = 0.74, p = 0.036). Digit ratio may not only have predictive value in risk but also prognosis of prostatic cancer. This finding suggests that low 2D:4D can be used as prognostic factors to identify patients with a poor prognosis. These patients may benefit from more aggressive management.
format article
author Guanjian Li
Ke Sun
Jie Guo
Shixing Li
Bo Li
Jing Cao
Pengfei Lu
Jiajia Yang
Ying Zhang
Xin Yang
Le Gao
Yi He
Tao Cui
Bin Ma
author_facet Guanjian Li
Ke Sun
Jie Guo
Shixing Li
Bo Li
Jing Cao
Pengfei Lu
Jiajia Yang
Ying Zhang
Xin Yang
Le Gao
Yi He
Tao Cui
Bin Ma
author_sort Guanjian Li
title Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
title_short Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
title_full Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
title_fullStr Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
title_full_unstemmed Prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
title_sort prognostic significance of the digit ratio after hormone therapy for prostate cancer: a prospective multicenter study
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/5c38dd54e6f544a78063c2493a254cae
work_keys_str_mv AT guanjianli prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT kesun prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT jieguo prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT shixingli prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT boli prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT jingcao prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT pengfeilu prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT jiajiayang prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT yingzhang prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT xinyang prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT legao prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT yihe prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT taocui prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
AT binma prognosticsignificanceofthedigitratioafterhormonetherapyforprostatecanceraprospectivemulticenterstudy
_version_ 1718395165331161088